$Passage BIO(PASG.US)$Passage Bio Announced Initial Safety And Biomarker Data From Three Cohort 1 Patients In The Ongoing Global Phase 1/2 UpliFT-D Trial Of PBFT02, An Adeno-associated Virus-delivery Gene Therapy For Frontotemporal Dementia With Granulin Mutations
Gainers -$联合通讯(CNSL.US)$+14.6%: Searchlight affirms 34.6% active holding; to evaluate the possibility of a further investment in or full acquisition. -$Voyager Therapeutics(VYGR.US)$+12.2%: agrees to licensing option with$诺华制药(NVS.US)$; Voyager receives $54 million upfront. -$荷兰全球保险(AEG.US)$+6%: provides update on Russian and Belarusian investments following invasion of Ukraine. -$AZZ Inc(AZZ.US)$+...
Kevin Matte : seem next level around 1.6 or so ^^